Published in J Clin Oncol on November 01, 1995
Systematic review of medical treatment in melanoma: current status and future prospects. Oncologist (2011) 2.89
Recent advances in the care of the patient with malignant melanoma. Ann Surg (1997) 1.92
The effect of tamoxifen and cisplatin on the disease-free and overall survival of patients with high risk malignant melanoma. Br J Cancer (2000) 1.45
Adjuvant therapy of melanoma with interferon: lessons of the past decade. J Transl Med (2008) 1.28
Adjuvant therapy for melanoma. Cancer J (2012) 1.01
Anticancer Cytokines: Biology and Clinical Effects of Interferon-α2, Interleukin (IL)-2, IL-15, IL-21, and IL-12. Semin Oncol (2015) 0.89
Adjuvant immunotherapy of melanoma and development of new approaches using the neoadjuvant approach. Clin Dermatol (2013) 0.81
Adjuvant high-dose interferon for cutaneous melanoma is most beneficial for patients with early stage III disease. Cancer (2008) 0.80
Adjuvant therapy: melanoma. J Skin Cancer (2011) 0.78
Calibration of quality-adjusted life years for oncology clinical trials. J Pain Symptom Manage (2013) 0.76
Malignant Melanoma. Healthcare (Basel) (2013) 0.75
Malignant melanoma (non-metastatic). BMJ Clin Evid (2007) 0.75
The Role of Regional Therapies for in-Transit Melanoma in the Era of Improved Systemic Options. Cancers (Basel) (2015) 0.75
Adjuvant therapy for melanoma: How should we respond to high-dose interferon? Br J Cancer (1998) 0.75
Cancer screening behaviors and attitudes of women in southeastern Minnesota. JAMA (1995) 2.23
Tilt table testing for assessing syncope. American College of Cardiology. J Am Coll Cardiol (1996) 1.92
Chemotherapeutic trial to control enterobiasis in schoolchildren. Korean J Parasitol (1997) 1.86
Randomized clinical trial of diethylstilbestrol versus tamoxifen in postmenopausal women with advanced breast cancer. N Engl J Med (1981) 1.70
Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741. Ann Oncol (2005) 1.67
[Identification and grouping of pain patients according to claims data]. Schmerz (2010) 1.64
Predicting sentinel and residual lymph node basin disease after sentinel lymph node biopsy for melanoma. Cancer (2000) 1.62
Renal failure and rhabdomyolysis associated with sitagliptin and simvastatin use. Diabet Med (2008) 1.60
Pulmonary chemoreflexes elicited by intravenous injection of lactic acid in anesthetized rats. J Appl Physiol (1985) (1996) 1.58
Malignant lymphoma of the spleen. A review of 49 cases in which the diagnosis was made at splenectomy. Cancer (1966) 1.54
A comparative evaluation of marketed analgesic drugs. N Engl J Med (1972) 1.50
Olsalazine is contraindicated during pelvic radiation therapy: results of a double-blind, randomized clinical trial. Int J Radiat Oncol Biol Phys (1996) 1.50
Reducing myoclonus after etomidate. Anesthesiology (1999) 1.38
Electromechanical-assisted training for walking after stroke. Cochrane Database Syst Rev (2007) 1.38
[Neglect of tuberculosis in medical education. How medical students perceive the incidence of tuberculosis in Germany]. Med Klin (Munich) (1998) 1.38
A recombinant immunotoxin containing a disulfide-stabilized Fv fragment. Proc Natl Acad Sci U S A (1993) 1.35
Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin chemotherapy. Cancer J Sci Am (2006) 1.27
Phase II trial of nitrogen mustard, vincristine, and procarbazine in patients with recurrent glioma: North Central Cancer Treatment Group results. J Clin Oncol (1998) 1.26
Experimental studies of the breakdown of Epontol: determination of propanidid in human serum. Br J Anaesth (1968) 1.26
Phase II clinical trial of isophosphamide (NSC-109724) in patients with advances breast cancer. Cancer Chemother Rep (1975) 1.25
Environmentally relevant xenoestrogen tissue concentrations correlated to biological responses in mice. Environ Health Perspect (2000) 1.23
The use of electroencephalography to measure recovery time after intravenous anaesthesia. Br J Anaesth (1966) 1.21
The first Korean case of human pulmonary dirofilariasis. Yonsei Med J (2000) 1.20
[Treatment of refractory epilepsy with dipropyl acetate]. Munch Med Wochenschr (1973) 1.20
Cardiac rhythm after the Mustard operation for complete transposition of the great arteries. N Engl J Med (1984) 1.19
Evaluation of a supermarket intervention to increase consumption of fruits and vegetables. Am J Health Promot (1997) 1.18
Mucinous cystadenoma coexisting with stromal tumor with minor sex-cord elements of the ovary: a case report. J Korean Med Sci (2001) 1.17
Breast biopsy: a comparative study of stereotaxically guided core and excisional techniques. AJR Am J Roentgenol (1994) 1.17
Reverse engineering of gene regulatory networks. IET Syst Biol (2007) 1.16
The Upper Midwest Health Study: a case-control study of primary intracranial gliomas in farm and rural residents. J Agric Saf Health (2006) 1.15
Utility of follow-up tests for detecting recurrent disease in patients with malignant melanomas. JAMA (1995) 1.15
A phase II trial of imatinib (ST1571) in patients with c-kit expressing relapsed small-cell lung cancer: a CALGB and NCCTG study. Ann Oncol (2005) 1.15
Randomized trial of bilateral oophorectomy versus tamoxifen in premenopausal women with metastatic breast cancer. J Clin Oncol (1986) 1.15
Improved binding and antitumor activity of a recombinant anti-erbB2 immunotoxin by disulfide stabilization of the Fv fragment. J Biol Chem (1994) 1.14
Three consecutive phase II studies of recombinant interferon alfa-2a in advanced malignant melanoma. Updated analyses. Cancer (1987) 1.12
Broiler litter supplementation improves storage and feed-nutritional value of sawdust-based spent mushroom substrate. Bioresour Technol (2007) 1.12
Relief of pain by oral medications. A controlled evaluation of analgesic combinations. JAMA (1974) 1.12
Disulfide stabilization of antibody Fv: computer predictions and experimental evaluation. Protein Eng (1995) 1.10
Congenital cholesteatoma of mastoid origin. J Laryngol Otol (2007) 1.07
Engineering interchain disulfide bonds into conserved framework regions of Fv fragments: improved biochemical characteristics of recombinant immunotoxins containing disulfide-stabilized Fv. Protein Eng (1994) 1.07
Locomotor training for walking after spinal cord injury. Cochrane Database Syst Rev (2008) 1.07
Stabilization of the Fv fragments in recombinant immunotoxins by disulfide bonds engineered into conserved framework regions. Biochemistry (1994) 1.06
PS-341 and gemcitabine in patients with metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group (NCCTG) randomized phase II study. Ann Oncol (2005) 1.05
Histamine enhances vagal pulmonary C-fiber responses to capsaicin and lung inflation. Respir Physiol (1993) 1.04
Myelodysplastic syndromes. A clinical and pathologic analysis of 109 cases. Cancer (1985) 1.04
DNA methylation and ovarian cancer. I. Analysis of CpG island hypermethylation in human ovarian cancer using differential methylation hybridization. Gynecol Oncol (2001) 1.03
[Intramuscular application of midazolam. Its effect upon CNS and respiration (author's transl)]. Arzneimittelforschung (1981) 1.03
Cell cycle effects of nonsteroidal anti-inflammatory drugs and enhanced growth inhibition in combination with gemcitabine in pancreatic carcinoma cells. J Pharmacol Exp Ther (2001) 1.02
A phase III study of radiation therapy plus carmustine with or without recombinant interferon-alpha in the treatment of patients with newly diagnosed high-grade glioma. Cancer (2001) 1.02
FDG-PET sensitivity for melanoma lymph node metastases is dependent on tumor volume. J Surg Oncol (2001) 1.02
Association between polymorphisms of ethanol-metabolizing enzymes and susceptibility to alcoholic cirrhosis in a Korean male population. J Korean Med Sci (2001) 0.99
Effect of body weight on the pharmacokinetics of cyclophosphamide in breast cancer patients. Cancer Chemother Pharmacol (1987) 0.98
Pharmacokinetics and pharmacodynamics of propofol in a new solvent. Anesth Analg (1997) 0.98
Acute effects of acrolein on breathing: role of vagal bronchopulmonary afferents. J Appl Physiol (1985) (1992) 0.97
Randomized trial of tamoxifen alone or combined with aminoglutethimide and hydrocortisone in women with metastatic breast cancer. J Clin Oncol (1986) 0.97
Phase II study of docetaxel in advanced soft tissue sarcomas. Am J Clin Oncol (1996) 0.97
Phase III placebo-controlled trial of capsaicin cream in the management of surgical neuropathic pain in cancer patients. J Clin Oncol (1997) 0.96
Phase II study of high-dose tamoxifen (NSC-180973) in patients with disseminated malignant melanoma. Cancer (1982) 0.96
Phase II study of tamoxifen in patients with disseminated malignant melanoma. Cancer Treat Rep (1980) 0.96
Immunomodulating drugs in multiple sclerosis: compliance, satisfaction and adverse effects evaluation in a German multiple sclerosis population. Curr Med Res Opin (2007) 0.95
Controlled evaluation of adriamycin (NSC-123127) in patients with disseminated breast cancer. Cancer Chemother Rep (1975) 0.95
[Ketamine racemate or S-(+)-ketamine and midazolam. The effect on vigilance, efficacy and subjective findings]. Anaesthesist (1992) 0.95
The urinary excretion of nucleosides of ribonucleic acid by patients with advanced cancer. Cancer (1975) 0.94
Randomized study of systemic chemotherapy following complete excision of nonosseous sarcomas. J Clin Oncol (1984) 0.93
Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia. J Clin Oncol (1993) 0.93
Characterization and expression of a novel alternatively spliced human angiopoietin-2. J Biol Chem (2000) 0.93
Complete responders to chemotherapy in metastatic breast cancer. Characterization and analysis. JAMA (1979) 0.93
Pulmonary chemoreflex sensitivity is enhanced by prostaglandin E2 in anesthetized rats. J Appl Physiol (1985) (1995) 0.93
Primary mediastinal choriocarcinoma. Mayo Clin Proc (1968) 0.91
A design for phase II testing of anticancer agents within a phase III clinical trial. Control Clin Trials (1988) 0.91
Randomized double-blind placebo-controlled trial of cisplatin and etoposide plus megestrol acetate/placebo in extensive-stage small-cell lung cancer: a North Central Cancer Treatment Group study. J Clin Oncol (1996) 0.91
Multicentre hydrogen bonds in a 2:1 arylsulfonylimidazolone hydrochloride salt. Acta Crystallogr C (2000) 0.91
Phase III clinical trial of the combination of cisplatin, dacarbazine, and carmustine with or without tamoxifen in patients with advanced malignant melanoma. J Clin Oncol (1999) 0.91
[The language of pediatric asthma patients. A study of symptom description]. Monatsschr Kinderheilkd (1993) 0.90
Phase II trials of recombinant leukocyte A interferon in disseminated malignant melanoma: results in 96 patients. Cancer Treat Rep (1986) 0.90
Effect of substituents on benzenesulfonyl motif of 4-phenyl-1-arylsulfonylimidazolidinones for their cytotoxicity. Arch Pharm Res (2000) 0.90
Characterization and predictors of prostate specific antigen progression rates after radical retropubic prostatectomy. J Urol (2000) 0.90
Identification of a domain containing B-cell epitopes in hepatitis C virus E2 glycoprotein by using mouse monoclonal antibodies. J Virol (1999) 0.90
A preliminary assessment of factors associated with recurrent disease in a surgical adjuvant clinical trial for patients with breast cancer with special emphasis on the aggressiveness of therapy. Am J Clin Oncol (1982) 0.89
Comparison of diagnostic markers with repeated measurements: a non-parametric ROC curve approach. Stat Med (2000) 0.89
Phase II study of 5-fluorouracil and leucovorin in recurrent primary brain tumor. J Neurooncol (1996) 0.89
Prospective analysis of quality of life in elderly patients treated with adjuvant chemotherapy for non-small-cell lung cancer. Ann Oncol (2013) 0.89
Primate antibody response to immunotoxin: serological and computer-aided analysis of epitopes on a truncated form of Pseudomonas exotoxin. Infect Immun (1994) 0.89
Phase II study of high-dose megestrol acetate in patients with advanced malignant melanoma. Cancer Treat Rep (1982) 0.88
Electron microscopic study of the cases of minimal change nephrotic syndrome with mesangial IgA deposition. Yonsei Med J (1992) 0.87
Clinical comparison of adriamycin and a combination of methyl-CCNU and imidazole carboxamide in disseminated malignant melanoma. Clin Pharmacol Ther (1976) 0.87
Influence of the earth's magnetic field on resting and activated EEG mapping in normal subjects. Int J Neurosci (1993) 0.87
Evaluation of fludarabine phosphate in patients with recurrent glioma. Am J Clin Oncol (1988) 0.87
Neuroendocrine differentiation is an independent prognostic factor in chemotherapy-treated nonsmall cell lung carcinoma. Cancer (1996) 0.86
Recombinant leukocyte A interferon (rIFN-alpha A) in the treatment of disseminated malignant melanoma. Analysis of complete and long-term responding patients. Cancer (1986) 0.86
Phase II trials of 5-fluorouracil and leucovorin in patients with metastatic gastric or pancreatic carcinoma. Cancer (1996) 0.86
A quantitative approach to determining disease response during therapy using multiple biologic markers: application to carcinoma of the breast. Cancer (1978) 0.86
Role of tachykinins in ozone-induced airway hyperresponsiveness to cigarette smoke in guinea pigs. J Appl Physiol (1985) (1997) 0.86
Randomized trial of radiation therapy (RT) plus dibromodulcitol (DBD) versus RT plus BCNU in high grade astrocytoma. J Neurooncol (1997) 0.86